I do not doubt for one minute the treatments. Nor do I doubt that they will receive FDA approval. I just don't. I have always maintained that. However, the state that BMSN will be in when approval does arrive, is something I can only speculate about. I have made it clear that I believe Koos is responsible in more ways than one, for this stock being decimated as it has all this time. Given the market potential of the treatments and the doctors that have worked so hard to see them ultimately come to fruition, there is no excuse for the way Koos has conducted business. Especially since he has all this business experience under his belt. None. 

It could be months before the FDA renders their decision. Maybe not. Who in the world knows now with the state of affairs that are upon us. If it does take many more months and this "chief" continues to operate as he has thus far, is there anything that indicates the stock will be worth nothing when at last it does come? The market potential for Hema pales to that of the dCellvax. No new IND applications are being accepted even if it is ready to be submitted. So, what is the plausible wait for this once it is finally accepted for consideration? How much more will he dilute?

Unless this "chief" shows some concern for his shareholders (most likely something insisted upon by his medical team and certainly not of his own free will I have no doubt) AND some actual business savvy, your guess is as good as mine where this stock will be in the future. Though, if history speaks for itself, well...you already know the answer.